Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Cue Biopharma Inc (NASDAQ: CUE) closed at $1.71 in the last session, up 14.77% from day before closing price of $1.49. In other words, the price has increased by $14.77 from its previous closing price. On the day, 0.82 million shares were traded. CUE stock price reached its highest trading level at $1.735 during the session, while it also had its lowest trading level at $1.323.
Ratios:
We take a closer look at CUE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.06 and its Current Ratio is at 2.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 13, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On November 21, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $7.Piper Sandler initiated its Overweight rating on November 21, 2022, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CUE now has a Market Capitalization of 102955168 and an Enterprise Value of 64414072. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.40 while its Price-to-Book (P/B) ratio in mrq is 3.85. Its current Enterprise Value per Revenue stands at 7.765 whereas that against EBITDA is -1.35.
Stock Price History:
Over the past 52 weeks, CUE has reached a high of $3.25, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 73.13%, while the 200-Day Moving Average is calculated to be 18.63%.
Shares Statistics:
According to the various share statistics, CUE traded on average about 626.85K shares per day over the past 3-months and 634350 shares per day over the past 10 days. A total of 60.21M shares are outstanding, with a floating share count of 59.65M. Insiders hold about 0.92% of the company’s shares, while institutions hold 28.25% stake in the company. Shares short for CUE as of 1728950400 were 1947424 with a Short Ratio of 3.11, compared to 1726185600 on 3557519. Therefore, it implies a Short% of Shares Outstanding of 1947424 and a Short% of Float of 3.25.
